S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 127 SEK -1.17%
Market Cap: 6.5B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note
Section:
 

Relative Value

The Relative Value of one SUS stock under the Base Case scenario is 203.41 SEK. Compared to the current market price of 127 SEK, Surgical Science Sweden AB is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUS Relative Value
Base Case
203.41 SEK
Undervaluation 38%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

7.8
P/S
P/S
Price to Sales
7.8
vs History
88
vs Industry
16
Median 3Y
10.5
Median 5Y
17.6
Industry
2.4
Forward
7.2
More Details
33.2
P/E
P/E
Price to Earnings
33.2
vs History
87
vs Industry
16
Median 3Y
45.2
Median 5Y
96.6
Industry
22.9
Forward
44.2
More Details
43.4
P/OCF
P/OCF
Price to OCF
43.4
vs History
68
vs Industry
11
Median 3Y
55.4
Median 5Y
55.6
Industry
14.5
More Details
63.4
P/FCFE
P/FCFE
Price to FCFE
63.4
vs History
41
vs Industry
13
Median 3Y
62
Median 5Y
61.5
Industry
20.5
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
90
vs Industry
51
Median 3Y
2
Median 5Y
2.8
Industry
2.2
More Details
7
EV/S
EV/S
Enterprise Value to Sales
7
vs History
88
vs Industry
16
Median 3Y
9.8
Median 5Y
17.3
Industry
2.4
Forward
6.4
More Details
10.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.3
vs History
88
vs Industry
19
Median 3Y
14.6
Median 5Y
23.3
Industry
5
More Details
39.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
39.9
vs History
74
vs Industry
7
Median 3Y
45.6
Median 5Y
83.6
Industry
12.6
Forward
24.7
More Details
39.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.9
vs History
82
vs Industry
9
Median 3Y
48.6
Median 5Y
104.7
Industry
17.1
Forward
30.3
More Details
39
EV/OCF
EV/OCF
Enterprise Value to OCF
39
vs History
69
vs Industry
13
Median 3Y
52.4
Median 5Y
53.5
Industry
14.1
More Details
58.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
58.6
vs History
61
vs Industry
12
Median 3Y
69.3
Median 5Y
69.3
Industry
17.7
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
90
vs Industry
47
Median 3Y
1.9
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

SUS Competitors Multiples
Surgical Science Sweden AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Surgical Science Sweden AB
STO:SUS
6.6B SEK 7.8 33.2 39.9 39.9
US
Abbott Laboratories
NYSE:ABT
204.7B USD 5 35.5 20.7 30.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD 23 80.6 68.7 85.3
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.7
US
Boston Scientific Corp
NYSE:BSX
124.8B USD 7.8 69.6 32 45.8
IE
Medtronic PLC
NYSE:MDT
114.5B USD 3.5 29.2 15.2 21.7
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.4 47.9 15.4 27.3
DE
Siemens Healthineers AG
XETRA:SHL
53.5B EUR 2.4 28.7 16.6 24.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
339.1B CNY 9.2 26.7 23.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
40B USD 7.1 9.6 22.2 24.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD 2 23.7 14.7 18.1

See Also

Summary
SUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUS stock valuation using valuation multiples.
Wall Street Estimates
SUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 194,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.